Browse our comprehensive library of diagnostic capabilities. We provide over 200 NABL accredited radiology scans and automated clinical pathology investigations.
First of all, a Ultra-Deep NGS Test is a high-precision Next-Generation Sequencing (NGS) assay designed to analyze a curated set of genes known to cause a specific disease or clinical phenotype. Essentially, by concentrating sequencing power on 10 to 500 target genes (such as Hereditary Breast Cancer panels, Cardiac Arrythmia panels, or Epilepsy panels), Ultra-Deep NGS Tests achieve ultra-high coverage depth (>500X) with 99.9% sensitivity. Consequently, physicians receive fast, actionable diagnostic findings without uninterpretable genomic noise.
Furthermore, book your Ultra-Deep NGS Test at Henotic Diagnostics for authoritative diagnostic accuracy. In addition, our accredited genomic laboratory operates 24/7 with convenient home sample collection services.
To begin with, a Ultra-Deep NGS Test is a specialized genomic test that evaluates a predefined selection of genes directly associated with a specific medical condition, hereditary cancer syndrome, or organ system disease. At the same time, experts at Henotic Diagnostics utilize targeted hybrid-capture Next-Generation Sequencing to achieve exceptional diagnostic clarity.
Furthermore, comfortable reception lounge providing supportive patient registration for Ultra-Deep NGS Test blood draws
What Does Targeted Gene Panel Evaluate?
Specifically, Ultra-Deep NGS Tests detect pathogenic single nucleotide variants (SNVs), small indels, splice site mutations, and gene copy number alterations in disease-focused gene sets. Consequently, by focusing exclusively on relevant genes, bioinformatic workflows minimize variants of uncertain significance (VUS). Furthermore, deep >500X coverage allows detection of low-level somatic mutations in tumor tissue. As a result, oncologists and cardiologists get fast clinical guidance. In fact, to review targeted panel guidelines, consult the NIH NHGRI Targeted Gene Panel Guide.
In general, unlike broad Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS), a Ultra-Deep NGS Test isolates and sequences only the genomic regions directly involved in a patient’s suspected illness. Essentially, custom molecular probes capture target exons with extreme efficiency. Therefore, sequencing depth is maximized (>500X) while reducing test turnaround time to 7 days. Additionally, to read about clinical targeted NGS panel developments, examine the Nature Reviews Clinical Oncology journal.
Additionally, high-throughput NGS sequencers process targeted multigene panels at >500X depth for ultra-sensitive variant detection
What Does a Targeted Gene Panel Check?
Overall, targeted panels are customized for specific medical specialties:
Key Specialty Targeted Gene Panels Evaluated
✓
Hereditary Cancer Panels: First, screens BRCA1, BRCA2, TP53, Lynch syndrome genes (MLH1, MSH2), and PALB2 for hereditary risk.
✓
Cardiovascular Disease Panels: Second, profiles hypertrophic cardiomyopathy, Long QT syndrome, and familial hypercholesterolemia genes.
✓
Epilepsy & Neurogenetics Panels: In addition, sequences channelopathy genes (SCN1A, KCNQ2) and hereditary neuropathy genes. Review the ClinVar NCBI variant database.
✓
Somatic Precision Oncology Panels: Finally, evaluates EGFR, KRAS, ALK, and BRAF in FFPE tumor tissues for targeted therapies.
In addition, bioinformatic software maps high-depth targeted gene coverage plots and ACMG variant classifications
When Is Targeted Gene Panel Recommended?
For example, oncologists order Ultra-Deep NGS Tests when a patient has a strong family history of breast, ovarian, or colorectal cancer to guide risk reduction strategies. In particular, cardiologists recommend cardiac panels for patients with unexplained sudden cardiac arrest or early-onset cardiomyopathy. Moreover, oncologists order somatic tumor panels to select FDA-approved targeted therapies (such as PARP inhibitors or TKI therapy). In addition, to review ACMG panel testing guidelines, examine the ACMG Medical Genetics Guidelines.
Moreover, expert geneticists interpret Ultra-Deep NGS Test results to guide targeted clinical treatments and family screening
Clinical Superiority: Targeted NGS Panels vs. Broad Untargeted Exomes
Why Targeted Gene Panels Outperform Broad Tests for Specific Phenotypes
Ideally, when a patient presents with a distinct disease phenotype, a Ultra-Deep NGS Test provides deeper coverage (>500X vs ~100X in WES), ensuring difficult exon regions are thoroughly sequenced. In addition, targeted panels virtually eliminate secondary incidental findings and ambiguous VUS reports. Indeed, to review global diagnostic health standards, consult the WHO Medical Diagnostics Fact Sheet.
Targeted Gene Panel Cost Guide
Targeted Panel Service
Approximate Cost (₹)
Hereditary Cancer Targeted Panel (BRCA1/2 + 25 Genes)
First, hereditary cancer panel pricing is ₹12,000 – ₹18,000.
Cardiomyopathy / Arrhythmia Targeted Panel
Second, cardiac targeted panel pricing is ₹15,000 – ₹20,000.
Epilepsy & Neurogenetics Targeted Panel
In addition, neurogenetics panel pricing is ₹16,000 – ₹22,000.
Finally, somatic tumor panel pricing is ₹18,000 – ₹25,000.
Comparison: Targeted Gene Panel vs. Whole Exome (WES) vs. Whole Genome (WGS)
On one hand, Whole Exome Sequencing evaluates all 20,000 coding genes, whereas a Ultra-Deep NGS Test focuses exclusively on known disease genes with deeper coverage (>500X vs ~100X) at faster turnaround times. Consequently, targeted panels are the preferred first-line test when clinical features point to a specific disease category. In fact, review the PubMed Clinical Targeted Panel Review.
Feature
Targeted Gene Panel
Whole Exome Sequencing (WES)
Gene Targets
First, 10 to 500 disease-specific genes.
However, all ~20,000 coding genes.
Sequencing Depth
Second, ultra-deep >500X coverage.
In contrast, standard ~100X coverage.
Turnaround Time
In addition, fast report within 7 to 10 days.
Meanwhile, 14 to 21 business days.
VUS Frequency
Finally, minimal uninterpretable VUS results.
Likewise, higher VUS discovery rates.
Frequently Asked Questions
What is a Targeted Gene Panel?▼
First, a Ultra-Deep NGS Test is a disease-focused NGS assay that sequences a curated set of genes linked to a specific medical condition.
What are the advantages of a Targeted Gene Panel over Exome Sequencing?▼
In addition, Targeted Gene Panels offer higher sequencing depth (>500X), lower VUS rates, faster turnaround times, and affordable cost.
What sample type is required for Targeted Gene Panel testing?▼
Generally, 4-6 mL of peripheral blood in EDTA tubes, FFPE tumor tissue blocks, or saliva are accepted.
Do I need to fast before a Targeted Gene Panel test?▼
Because targeted panels evaluate constitutional or somatic DNA, fasting is unnecessary.
How long until I receive diagnostic Targeted Gene Panel results?▼
Fortunately, detailed clinical bioinformatic targeted panel reports are delivered within 7 to 10 business days.
What is the cost of Targeted Gene Panel testing?▼
Overall, high-precision Targeted Gene Panels range from ₹12,000 to ₹25,000 depending on gene count and panel scope.
Quick Appointment Booking
Schedule your Targeted Gene Panel test with accredited genomic experts.
MBBS, MD (Geneticist) · 15+ Years Clinical Experience
Furthermore, your Targeted Gene Panel results are evaluated by accredited molecular geneticists and bioinformaticians. Consequently, comprehensive reports empower physicians with clear actionable treatment options.
Real feedback from patients who completed Targeted Gene Panel testing with us.
⭐⭐⭐⭐⭐
“The Hereditary Breast Cancer Targeted Panel identified a pathogenic BRCA2 variant quickly. Furthermore, my oncologist started preventive risk reduction immediately.”
– Sunita P.
Verified Patient Review
⭐⭐⭐⭐⭐
“Extremely clear cardiac targeted panel report identifying a MYH7 cardiomyopathy mutation. In addition, report delivery took only 7 days.”
– Rajesh M.
Verified Patient Review
⭐⭐⭐⭐⭐
“Excellent NABL accredited molecular diagnostic center. Henotic Diagnostics is our trusted referral laboratory for targeted gene panel testing.”
If you require Targeted Gene Panel testing for hereditary cancer, cardiac, neurological, or somatic tumor risk, do not delay. Call to schedule your sample collection.
Henotic Diagnostics
Second floor, Millennium Empire, Business Park, Plot No 47, D Mart Rd, Sector 15, Kharghar, Navi Mumbai, Panvel, Maharashtra 410210
You can book your Targeted Gene Panel appointment at our Navi Mumbai center through multiple convenient channels: call us directly at 088793 27184, send a WhatsApp message for instant booking, or use the online booking form on our website. Walk-in appointments are also welcome based on slot availability. We recommend advance booking to ensure zero wait times.
Yes, Henotic Diagnostics Navi Mumbai is empanelled with all major insurance companies and TPAs (Third Party Administrators) including Star Health, ICICI Lombard, New India Assurance, HDFC Ergo, Max Bupa, Bajaj Allianz, and many more. We offer cashless processing for Targeted Gene Panel where applicable. Please carry your insurance card and a valid ID for seamless processing.
At Henotic Diagnostics Navi Mumbai, most Targeted Gene Panel reports are delivered within 2-6 hours for routine tests. Critical and urgent reports are expedited on a priority basis. All reports are delivered digitally via WhatsApp, email, and our secure online patient portal. Hard copies are also available at the center upon request. You will receive an SMS/WhatsApp notification the moment your report is ready.
Henotic Diagnostics Navi Mumbai operates 24 hours a day, 7 days a week, including Sundays and public holidays. This means you can schedule your Targeted Gene Panel at a time that is most convenient for you — early morning, late evening, or even overnight for emergency requirements. Our radiology and pathology departments maintain round-the-clock availability.
Yes, Henotic Diagnostics Navi Mumbai is fully accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) and ISO 9001:2015 certified. Our radiology equipment also complies with AERB (Atomic Energy Regulatory Board) safety standards. These accreditations ensure that every Targeted Gene Panel performed at our facility meets the highest national and international quality benchmarks for accuracy, safety, and reliability.
